Cargando…
Use of Prostaglandin E1 in the Management of Congenital Diaphragmatic Hernia–A Review
Congenital diaphragmatic hernia (CDH) is a rare congenital anomaly, whose presentation is complicated by pulmonary hypertension (PH), pulmonary hypoplasia, and myocardial dysfunction, each of which have significant impact on short-term clinical management and long-term outcomes. Despite many advance...
Autores principales: | Hari Gopal, Srirupa, Patel, Neil, Fernandes, Caraciolo J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283565/ https://www.ncbi.nlm.nih.gov/pubmed/35844758 http://dx.doi.org/10.3389/fped.2022.911588 |
Ejemplares similares
-
Inotropic score and vasoactive inotropic score as predictors of outcomes in congenital diaphragmatic hernia: A single center retrospective study
por: Hari Gopal, Srirupa, et al.
Publicado: (2023) -
Editorial: Unsolved problems in congenital diaphragmatic hernia
por: Tibboel, Dick, et al.
Publicado: (2023) -
The heart in congenital diaphragmatic hernia: Knowns, unknowns, and future priorities
por: Patel, Neil, et al.
Publicado: (2022) -
Cellular Origin(s) of Congenital Diaphragmatic Hernia
por: Edel, Gabriëla G., et al.
Publicado: (2021) -
Extracorporeal Membrane Oxygenation in Congenital Diaphragmatic Hernia
por: Rafat, Neysan, et al.
Publicado: (2019)